François Davodeau

The paper develops a pipeline to generate potent Affitins targeting SARS-CoV-2 spike protein RBD, achieving high neutralization potency with IC50 values as low as 0.8 pM.

This paper compares the therapeutic index of IgG and F(ab)2 fragments in preclinical radioimmunotherapy models, finding F(ab)2 improves therapeutic outcomes.

This study shows that human NK cells can directly inhibit growth of extracellular S. aureus and hypervirulent P. aeruginosa without accessory cells, as evidenced by degranulation and reduced bacterial growth.